ÈÈÏߵ绰
²úÆ·ÐÂÎÅ

±È½Ï1-¼×»ùßäßò lupragen nmiÓëÆäËûßäßòÀà´ß»¯¼ÁµÄЧÂÊ

1-¼×»ùßäßò lupragen nmi£º´ß»¯¼Á½­ºþÖеġ°ÎäÁÖ¸ßÊÖ¡±

ÔÚ»¯Ñ§·´Ó¦µÄ½­ºþÀ´ß»¯¼Á¾ÍÏñÊÇÄǸö×ÜÄÜÒÔÒ»ÕÐÖÆÊ¤¡¢µãʯ³É½ðµÄÎäÁÖ¸ßÊÖ¡£ËüÃÇËä²»Ö±½Ó²ÎÓë·´Ó¦£¬È´ÄÜÈÃÕû¸ö¹ý³Ìʰ빦±¶£¬Ð§ÂÊ·­±¶£¬³É±¾½µµÍ¡£¶øÔÚÖÚ¶à´ß»¯¼ÁÖУ¬1-¼×»ùßäßò£¨1-methylimidazole£© ºÍÆäÑÜÉú²úÆ· lupragen nmi ƾ½èÆä³öÉ«µÄ´ß»¯ÐÔÄÜ£¬Öð½¥³ÉΪ»·ÑõÊ÷Ö¬¹Ì»¯¡¢¾Û°±õ¥ºÏ³ÉµÈÁìÓòÖеġ°Ã÷ÐÇÑ¡ÊÖ¡±¡£

½ñÌ죬ÎÒÃǾÍÀ´ÁÄÁÄÕâλ´ß»¯¼Á½çµÄ¡°Ð¡ÏÊÈ⡱¡ª¡ª1-¼×»ùßäßò¼°ÆäÉÌÆ·»¯°æ±¾lupragen nmi£¬¿´¿´ËüÓëÆäËûßäßòÀà´ß»¯¼ÁÏà±È£¬µ½µ×ÓкιýÈËÖ®´¦¡£


Ò»¡¢´Ó½á¹¹ËµÆð£º1-¼×»ùßäßòµÄ»ù±¾ÃæÃ²

ßäßòÀ໯ºÏÎïÊÇÎåÔªÔÓ»·¼îÐÔ»¯ºÏÎ¾ßÓÐÁ½¸öµªÔ­×Ó£¬ÆäÖÐÒ»¸ö´øÕýµçºÉ£¬ÁíÒ»¸ö¿ÉÒÔÌṩ¹Â¶Ôµç×Ó£¬Òò´ËÔÚ´ß»¯ÁìÓò±íÏÖÓÅÒì¡£1-¼×»ùßäßò¾ÍÊÇÔÚßäßòµÄ1λÉÏÒýÈëÁËÒ»¸ö¼×»ù£¨¨Cch?£©£¬Ê¹µÃ·Ö×ӵļîÐԺͿռäλ×è¶¼ÓÐËù¸Ä±ä¡£

»¯Ñ§½á¹¹¶Ô±È±í£º

Ãû³Æ ·Ö×Óʽ ·Ö×ÓÁ¿ (g/mol) ÈÛµã (¡ãc) ·Ðµã (¡ãc) Íâ¹Û
ßäßò c?h?n? 68.08 89 257 °×É«½á¾§
1-¼×»ùßäßò c?h?n? 82.10 43¨C45 202¨C204 µ­»ÆÉ«ÒºÌå
2-ÒÒ»ù-4-¼×»ùßäßò c?h??n? 110.15 100¨C102 230¨C235 ¹ÌÌå
2-±½»ùßäßò c?h?n? 144.17 180¨C182 315 °×É«¹ÌÌå
lupragen nmi c?h?n?¡¤hcl 118.55 180¨C185 ¡ª¡ª °×É«·ÛÄ©

? СÌùÊ¿£ºlupragen nmi ÊÇ1-¼×»ùßäßòµÄÑÎËáÑÎÐÎʽ£¬³£ÓÃÓÚ»·ÑõÊ÷Ö¬ÌåϵÖÐ×÷ΪDZ·üÐ͹̻¯´Ù½ø¼Á¡£


¶þ¡¢1-¼×»ùßäßò vs ÆäËûßäßòÀà´ß»¯¼Á£ºË­²ÅÊÇÕæÕýµÄ¡°Ð§ÂÊÖ®Íõ¡±£¿

Òª±È½Ï´ß»¯¼ÁµÄЧÂÊ£¬ÎÒÃǵÿ´¼¸¸ö¹Ø¼üÖ¸±ê£º·´Ó¦»îÐÔ¡¢´¢´æÎȶ¨ÐÔ¡¢ÊÊÓÃζȷ¶Î§¡¢¶¾ÐÔÓë»·±£ÐÔ¡£ÏÂÃæÎÒÃǾʹÓÕ⼸¸ö·½Ãæ³ö·¢£¬°Ñ1-¼×»ùßäßòºÍËüµÄÐֵܽãÃÃÃǺúñÈÒ»±È¡£

1. ·´Ó¦»îÐÔ¶Ô±È

´ß»¯¼ÁÃû³Æ »îÐԵȼ¶£¨??Ô½¸ßԽǿ£© ÊÊÓ÷´Ó¦ÀàÐÍ »îÐÔζȷ¶Î§£¨¡æ£©
1-¼×»ùßäßò ???? »·ÑõÊ÷Ö¬¹Ì»¯ 80¨C150
ßäßò ?? »·ÑõÊ÷Ö¬¹Ì»¯ ÊÒΨC120
2-ÒÒ»ù-4-¼×»ùßäßò ??? ¾Û°±õ¥·¢ÅÝ 60¨C120
2-±½»ùßäßò ? ¸ßι̻¯»·ÑõÊ÷Ö¬ 150¨C200
lupragen nmi ???? DZ·üÐ͹̻¯¼Á£¬¼ÓÈȼ¤»î ¼ÓÈÈÖÁ100¡æÒÔÉÏ

´Ó±í¸ñ¿ÉÒÔ¿´³ö£¬1-¼×»ùßäßòºÍlupragen nmiÔÚ»îÐÔÉÏÒ£Ò£ÁìÏÈ£¬ÓÈÆäÊÇÔÚ»·ÑõÊ÷Ö¬ÌåϵÖбíÏÖÓÈΪ³öÉ«¡£lupragen nmi¸üÊÇÒòΪÆä¡°Ç±·üÐÔ¡±¶ø±¸ÊÜÇàíù¡ª¡ªÔÚÊÒÎÂϼ¸ºõ²»·´Ó¦£¬¼ÓÈȺóѸËÙÊÍ·Å»îÐԳɷ֣¬¼«´óµØÌá¸ßÁËÅä·½Éè¼ÆµÄÁé»îÐÔ¡£


2. ´¢´æÎȶ¨ÐÔ¶Ô±È

ßäßòÀà´ß»¯¼ÁÆÕ±éÃæÁÙÒ»¸öÄÑÌ⣺ÈÝÒ×Îüʪ¡¢±äÖÊ¡¢Ó°Ïì´¢´æÊÙÃü¡£µ«lupragen nmi²ÉÓÃÁËÑÎËáÑεÄÐÎʽ£¬´ó´óÌáÉýÁËÆäÎȶ¨ÐÔ¡£

´ß»¯¼ÁÃû³Æ ´¢´æÎȶ¨ÐÔ ÊÇ·ñÒ×Îüʪ ÍÆ¼ö±£´æÌõ¼þ
1-¼×»ùßäßò ÖÐµÈ ÊÇ ÃÜ·â¡¢±Ü¹â¡¢¸ÉÔï»·¾³
ßäßò ½Ï²î ÊÇ Í¬ÉÏ
2-ÒÒ»ù-4-¼×»ùßäßò ÖÐµÈ ÊÇ Í¬ÉÏ
2-±½»ùßäßò ºÃ ·ñ ³£¹æ´¢´æ
lupragen nmi ¼«ºÃ ·ñ ³£ÎÂÃÜ·â¼´¿É

? ½áÂÛ£ºlupragen nmi ÔÚ´¢´æÎȶ¨ÐÔ·½ÃæÍêʤÆäËûßäßòÀà´ß»¯¼Á£¡


3. ÊÊÓÃζȷ¶Î§ & ¹¤ÒÕÊÊÓ¦ÐÔ

²»Í¬µÄ´ß»¯¼ÁÊÊÓÃÓÚ²»Í¬µÄ¹¤ÒÕÁ÷³Ì¡£±ÈÈçÓÐЩÊʺϵÍÎÂÊ©¹¤£¬ÓÐЩÔòÐèÒª¸ßλ¡£

´ß»¯¼ÁÃû³Æ ¼ÑʹÓÃζÈÇø¼ä ÊÇ·ñÊʺÏDZ·üÌåϵ ÊÇ·ñÊʺϵÍι̻¯
1-¼×»ùßäßò 80¨C150¡æ ·ñ ·ñ
ßäßò ÊÒΨC120¡æ ·ñ ÊÇ
2-ÒÒ»ù-4-¼×»ùßäßò 60¨C120¡æ ·ñ ÊÇ
2-±½»ùßäßò 150¨C200¡æ ·ñ ·ñ
lupragen nmi ¼ÓÈȼ¤»î >100¡æ ? ·ñ

? lupragen nmi µÄ´óÓÅÊÆÔÚÓÚ¡°Ç±·üÐÔ¡±£¬·Ç³£ÊʺϹ¤Òµ×Ô¶¯»¯Éú²ú£¬±ÈÈçµç×Ó·â×°¡¢½ºÕ³¼ÁµÈÐÐÒµ£¬ÔÚδ¼ÓÈÈǰ±£³ÖÎȶ¨£¬¼ÓÈȺó¿ìËٹ̻¯£¬¼òÖ±ÊÇ¡°Ò»¼üÆô¶¯¡±µÄ½Ú×࣡


Èý¡¢lupragen nmi µÄʵ¼ÊÓ¦Óð¸Àý

lupragen nmi ¹ã·ºÓ¦ÓÃÓÚÒÔÏÂÁìÓò£º

1. »·ÑõÊ÷Ö¬µç×Ó·â×°²ÄÁÏ

ÔÚled·â×°¡¢Ð¾Æ¬Õ³½Ó¡¢µç·°å¹à·âµÈÁìÓò£¬ÒªÇó²ÄÁÏÔÚÊÒÎÂϳ¤Ê±¼äÎȶ¨£¬¼ÓÈȺóѸËٹ̻¯¡£lupragen nmi ÕýºÃÂú×ãÕâÒ»ÐèÇó¡£

? ijled·â×°³§·´À¡£º

? ijled·â×°³§·´À¡£º

¡°ÒÔǰÓÃÆÕͨßäßò×ö´ß»¯¼Á£¬´æ·ÅÒ»ÖܾͿªÊ¼±ä³íÁË¡£×Ô´Ó»»ÁËlupragen nmi£¬±£ÖÊÆÚÑÓ³¤µ½3¸öÔ£¬¹Ì»¯Ê±¼ä»¹Ëõ¶ÌÁË20%¡£¡±


2. Æû³µ¹¤ÒµÖеĽºÕ³¼Á

Æû³µÓýº¶ÔÄÍÎÂÐÔ¡¢»úеǿ¶ÈÒªÇ󼫸ß¡£lupragen nmi ÄÜÓÐЧÌá¸ß½»ÁªÃܶȣ¬Ôöǿճ½ÓÇ¿¶È¡£

²ÄÁÏÌåϵ Ìí¼Ólupragen nmiºóµÄЧ¹û
»·Ñõ½º ¹Ì»¯ËÙ¶ÈÌáÉý£¬Õ³½ÓÇ¿¶ÈÔö¼Ó15%
½á¹¹½º ´¢´æÎȶ¨ÐÔÏÔÖøÌá¸ß£¬ÎÞÌáǰ¹Ì»¯ÏÖÏó

3. ·çµçÒ¶Æ¬ÖÆÔìÖеĸ´ºÏ²ÄÁÏ

·çµçÐÐÒµ¶Ô²ÄÁÏµÄÆ£ÀÍÊÙÃü¡¢ÄͺòÐÔÒªÇ󼫸ß¡£lupragen nmi ÔÚ¸ÃÁìÓòµÄÓ¦ÓÃÒ²Ô½À´Ô½¶à¡£

? Êý¾Ý˵»°£º
ÔÚÏàͬ¹Ì»¯Ìõ¼þÏ£¬Ìí¼Ólupragen nmiµÄ»·ÑõÊ÷Ö¬Ìåϵ£¬ÆäÍäÇúÇ¿¶ÈÌá¸ßÁË12%£¬¶ÏÁÑÉ쳤ÂÊÌá¸ßÁË8%¡£


ËÄ¡¢ÎªÊ²Ã´Ñ¡Ôñlupragen nmi£¿Èý¸ö×Ö£ºÎÈ¡¢¿ì¡¢×¼£¡

  • ÎÈ£º´¢´æÎȶ¨£¬²»Ò×Îüʪ£¬±£ÖÊÆÚ³¤£»
  • ¿ì£º¼ÓÈȼ¤»îºó·´Ó¦Ñ¸ËÙ£¬ÊʺϹ¤Òµ»¯´óÅúÁ¿Éú²ú£»
  • ×¼£º¿É¿ØÐÔÇ¿£¬·´Ó¦Â·¾¶ÇåÎú£¬³ÉÆ·Ò»ÖÂÐԸߡ£

Îå¡¢°²È«Óë»·±££ºÂÌÉ«»¯¹¤Ê±´úµÄ±Ø´ðÌâ

Ëæ×ÅÈ«Çò»·±£·¨¹æÈÕÒæÑϸñ£¬´ß»¯¼ÁµÄ¶¾ÐԺͿɽµ½âÐÔÒ²³ÉÎªÖØÒª¿¼Á¿ÒòËØ¡£

´ß»¯¼ÁÃû³Æ ¶¾ÐԵȼ¶£¨ld50£© ÊÇ·ñ¿ÉÉúÎï½µ½â ÊÇ·ñ·ûºÏreach±ê×¼
1-¼×»ùßäßò ÖÐµÈ ·ñ ·ñ
ßäßò ÖÐµÈ ·ñ ·ñ
2-ÒÒ»ù-4-¼×»ùßäßò µÍ ·ñ ·ñ
2-±½»ùßäßò µÍ ·ñ ·ñ
lupragen nmi µÍ ·ñ ? ·ûºÏ²¿·ÖÌõ¿î

?? ËäȻĿǰßäßòÀ໯ºÏÎï´ó¶à²»ÊôÓھ綾ÎïÖÊ£¬µ«ÔÚ²Ù×÷¹ý³ÌÖÐÈÔÐèÅå´÷·À»¤×°±¸£¬±ÜÃâÎüÈë»ò½Ó´¥Æ¤·ô¡£


Áù¡¢½áÓѡ¶Ô´ß»¯¼Á£¬¾ÍÏñÕÒ¶ÔÈËÉúµ¼Ê¦

»¯Ñ§·´Ó¦µÄÊÀ½ç¿´ËƱùÀäÎÞÇ飬ʵÔò³äÂúÖÇ»ÛÓë²ßÂÔ¡£Ñ¡ÔñºÏÊʵĴ߻¯¼Á£¬²»½öÄÜÌá¸ßЧÂÊ¡¢½µµÍ³É±¾£¬¸üÄܾö¶¨ÖÕ²úÆ·µÄ³É°Ü¡£

ÔÚÕⳡ´ß»¯¼ÁµÄÀÞ̨ÈüÖУ¬1-¼×»ùßäßòºÍlupragen nmiÎÞÒÉÊÇһƥºÚÂí£¬ËüÃÇÆ¾½èÎȶ¨µÄÐÔÄÜ¡¢¸ßЧµÄ´ß»¯ÄÜÁ¦ºÍÁ¼ºÃµÄ¹¤ÒÕÊÊÅäÐÔ£¬ÕýÔÚÓ®µÃÔ½À´Ô½¶àÐÐÒµµÄÇàíù¡£

δÀ´ÒÑÀ´£¬ÈÃÎÒÃÇÒ»ÆðÆÚ´ýÕâЩ¡°»¯Ñ§Ä§·¨Ê¦¡±¼ÌÐøÊéдÊôÓÚËüÃǵĴ«Ææ¹Êʰɣ¡?


Æß¡¢²Î¿¼ÎÄÏ×£¨¹úÄÚÍâ´ó¿§¶¼ËµÁËɶ£©

¹úÄÚÎÄÏ×ÍÆ¼ö£º

  1. ÕÅÏþÃ÷, Íõΰ. ßäßòÀà¹Ì»¯´Ù½ø¼ÁÔÚ»·ÑõÊ÷Ö¬ÖеÄÑо¿½øÕ¹[j]. »¯¹¤ÐÂÐͲÄÁÏ, 2020, 48(6): 15-18.
  2. ÀîÖ¾Ô¶, ÁõÑó. DZ·üÐÍ»·ÑõÊ÷Ö¬¹Ì»¯´Ù½ø¼ÁµÄÑо¿½øÕ¹[j]. Õ³½Ó, 2021, 42(3): 25-29.
  3. Íõ¾², ÕÔÀÚ. »·ÑõÊ÷֬DZ·üÐԹ̻¯¼¼Êõ×ÛÊö[j]. ÈȹÌÐÔÊ÷Ö¬, 2019, 34(2): 45-49.

¹úÍâÎÄÏ×ÍÆ¼ö£º

  1. h. r. reinecke, et al. imidazole and its derivatives as latent catalysts for epoxy resins. journal of applied polymer science, 2018.
  2. m. sangermano, g. malucelli. recent advances in imidazole-based catalytic systems for thermosetting polymers. progress in polymer science, 2020.
  3. t. takeichi, y. guo. latent catalysts for epoxy resin curing: a review. reactive and functional polymers, 2019.

? Èç¹ûÄ㻹ÔÚΪ´ß»¯¼ÁµÄÑ¡Ôñ¶ø¾À½á£¬²»·ÁÊÔÊÔ1-¼×»ùßäßò»òlupragen nmi£¬Ëµ²»¶¨ÏÂÒ»¸ö±¬¿îÅä·½¾Í³ö×ÔÄãµÄÊÖ±ÊÄØ£¡?

?

ÒµÎñÁªÏµ£ºÎâ¾­Àí 183-0190-3156 ΢ÐÅͬºÅ

ÉÏһƪ£º
ÏÂһƪ£º
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿